Global strategic partnerships in regenerative medicine

Anna French; Jane Y Suh; Carol Y Suh; Lee Rubin; Richard Barker; Kim Bure; Brock Reeve; David A Brindley

doi:10.1016/j.tibtech.2014.05.007

Global strategic partnerships in regenerative medicine

Trends Biotechnol. 2014 Sep;32(9):436-40. doi: 10.1016/j.tibtech.2014.05.007.

Authors

Anna French¹, Jane Y Suh², Carol Y Suh³, Lee Rubin⁴, Richard Barker⁵, Kim Bure⁶, Brock Reeve⁷, David A Brindley⁸

Affiliations

¹ The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, OX3 7LG, UK. Electronic address: anna.french@casmi.org.uk.
² Harvard University Department of Stem Cell and Regenerative Biology, Cambridge, MA, 02138, USA.
³ Department of Genetics, Yale University, New Haven, CT 06520, USA; Section of Cardiovascular Medicine, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT 06520, USA; Yale Stem Cell Center, CT, 06520, USA.
⁴ Harvard University Department of Stem Cell and Regenerative Biology, Cambridge, MA, 02138, USA; Harvard Stem Cell Institute, Cambridge, MA, 02138, USA.
⁵ The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, OX3 7LG, UK.
⁶ Sartorius Stedim, Göttingen, 37079, Germany.
⁷ Harvard Stem Cell Institute, Cambridge, MA, 02138, USA.
⁸ Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Centre, University of Oxford, Oxford, OX3 7LD, UK; The Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, OX3 7LG, UK; Harvard Stem Cell Institute, Cambridge, MA, 02138, USA; Centre for Behavioral Medicine, UCL School of Pharmacy, University College London, London, WC1N 1AX, UK.

PMID: 25150363
DOI: 10.1016/j.tibtech.2014.05.007

Abstract

The approach to research and development in biomedical science is changing. Increasingly, academia and industry seek to collaborate, and share resources and expertise, by establishing partnerships. Here, we explore the co-development partnership landscape in the field of regenerative medicine, focusing on agreements involving one or more private entities. A majority of the largest biopharmaceutical companies have announced strategic partnerships with a specific regenerative medicine focus, signifying the growth and widening appeal of this emerging sector.

Keywords: cell therapies; regenerative medicine; stem cells; strategic partnerships; translation.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Cooperative Behavior*
Drug Industry*
Public-Private Sector Partnerships / organization & administration*
Public-Private Sector Partnerships / trends
Regenerative Medicine / methods*
Regenerative Medicine / trends
Research / organization & administration*
Research / trends
Universities*